Technical Analysis for LEGN - Legend Biotech Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 38.40 | 2.62% | 0.98 |
LEGN closed up 2.62 percent on Tuesday, November 19, 2024, on approximately normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Low | Weakness | 0.00% | |
Earnings Movers | Other | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 2.62% | |
New 52 Week Low | Weakness | 2.62% | |
Earnings Movers | Other | 2.62% | |
Oversold Stochastic | Weakness | 2.62% | |
New 52 Week Closing Low | Bearish | 0.55% | |
New 52 Week Low | Weakness | 0.55% | |
Lower Bollinger Band Touch | Weakness | 0.55% |
Alert | Time |
---|---|
Up 2% | about 12 hours ago |
Up 1% | about 12 hours ago |
60 Minute Opening Range Breakout | about 12 hours ago |
Down 1% | about 12 hours ago |
Lower Bollinger Band Support | about 13 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/18/2024
Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Cell Therapy Genscript Biotech Tax Investigation
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Cell Therapy Genscript Biotech Tax Investigation
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 70.13 |
52 Week Low | 36.92 |
Average Volume | 1,344,721 |
200-Day Moving Average | 51.00 |
50-Day Moving Average | 45.52 |
20-Day Moving Average | 42.06 |
10-Day Moving Average | 39.58 |
Average True Range | 2.20 |
RSI (14) | 32.89 |
ADX | 20.52 |
+DI | 13.70 |
-DI | 26.40 |
Chandelier Exit (Long, 3 ATRs) | 41.19 |
Chandelier Exit (Short, 3 ATRs) | 43.52 |
Upper Bollinger Bands | 47.35 |
Lower Bollinger Band | 36.77 |
Percent B (%b) | 0.15 |
BandWidth | 25.17 |
MACD Line | -2.25 |
MACD Signal Line | -1.97 |
MACD Histogram | -0.2736 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 40.72 | ||||
Resistance 3 (R3) | 40.48 | 39.47 | 40.33 | ||
Resistance 2 (R2) | 39.47 | 38.88 | 39.59 | 40.20 | |
Resistance 1 (R1) | 38.94 | 38.52 | 39.21 | 39.17 | 40.07 |
Pivot Point | 37.93 | 37.93 | 38.06 | 38.05 | 37.93 |
Support 1 (S1) | 37.39 | 37.34 | 37.66 | 37.63 | 36.73 |
Support 2 (S2) | 36.38 | 36.97 | 36.50 | 36.60 | |
Support 3 (S3) | 35.85 | 36.38 | 36.47 | ||
Support 4 (S4) | 36.08 |